Access Pharmaceuticals Inc. announced that at its annual general meeting held on May 7, 2013, the shareholders approved the certificate of incorporation to increase the number of authorized shares of common stock from 130,000,000 shares to 200,000,000 shares.

Access Pharmaceuticals Inc., Annual General Meeting, May 07, 2013., at 10:00 Central Standard Time. Location: Bingham McCutchen LLP. Agenda: To elect two Class 3 Directors to hold office for a term of three years and until their successors are elected and qualified; to consider an advisory vote on the compensation of the company’s executive officers; to consider an advisory vote on the frequency of future advisory votes on the compensation of the company’s executive officers; to consider and act upon a proposal to amend the company’s Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock from 130,000,000 shares to 200,000,000 shares; to amend the company’s 2005 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder; to ratify the appointment of Whitley Penn LLP as independent registered public accounting firm for the fiscal year ending December 31, 2013; and to transact such other business as may properly come before the meeting or any postponements or adjournments thereof.

Access Pharmaceuticals Inc. filed its 10-K on Mar 20, 2013 for the period ending Dec 31, 2012. In this report its auditor, Whitley Penn, gave an unqualified opinion expressing doubt that the company can continue as a going concern.